CONKWEST

Serial Number 77865619
Registration 3920852
800

Registration Progress

Application Filed
Nov 5, 2009
Under Examination
Jun 8, 2010
Approved for Publication
Apr 13, 2010
Published for Opposition
Apr 13, 2010
Registered
Feb 15, 2011

Trademark Image

CONKWEST

Basic Information

Serial Number
77865619
Registration Number
3920852
Filing Date
November 5, 2009
Registration Date
February 15, 2011
Published for Opposition
April 13, 2010
Renewal Date
February 15, 2021
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
800
Status Date
Aug 6, 2021
Registration
Registered
Classes
001 005

Rights Holder

IMMUNITYBIO, INC.

03
Address
3530 JOHN HOPKINS COURT
SAN DIEGO, CA 92121

Ownership History

ZelleRx Corporation

Original Applicant
03
Rancho Santa Fe, CA

ZelleRx Corporation

Owner at Publication
03
Rancho Santa Fe, CA

ZelleRx Corporation

Original Registrant
03
Rancho Santa Fe, CA

CONKWEST, INC.

New Owner After Registration #1
03
SAN DIEGO, CA

NANTKWEST, INC.

New Owner After Registration #2
03
San Diego, CA

IMMUNITYBIO, INC.

New Owner After Registration #3
03
SAN DIEGO, CA

Legal Representation

Attorney
Alicia M. Passerin

USPTO Deadlines

Next Deadline
2023 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2011-02-15)
Due Date
February 15, 2031
Grace Period Ends
August 15, 2031

Application History

36 events
Date Code Type Description Documents
Aug 6, 2021 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Aug 6, 2021 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
Aug 6, 2021 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Aug 3, 2021 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jun 9, 2021 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Apr 20, 2021 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Feb 15, 2020 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Aug 1, 2017 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Aug 1, 2017 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Jun 14, 2017 EROP I TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Loading...
May 24, 2017 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Apr 27, 2017 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 27, 2017 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 8, 2017 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Mar 8, 2017 PR23 O POST REGISTRATION ACTION MAILED - SEC. 8 & 15 Loading...
Jan 4, 2017 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Aug 19, 2015 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Apr 20, 2011 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Feb 15, 2011 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 11, 2011 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jan 8, 2011 REGV O LAW OFFICE REGISTRATION REVIEW COMPLETED Loading...
Jan 7, 2011 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jan 6, 2011 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jan 6, 2011 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Dec 7, 2010 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Dec 7, 2010 IUAF S USE AMENDMENT FILED Loading...
Jun 8, 2010 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 13, 2010 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 13, 2010 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 5, 2010 ALIE A ASSIGNED TO LIE Loading...
Mar 5, 2010 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Feb 11, 2010 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 11, 2010 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 13, 2009 MPMK O NOTICE OF PSEUDO MARK MAILED Loading...
Nov 12, 2009 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 9, 2009 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Cells for scientific, laboratory or medical research
First Use Anywhere: 20100300
First Use in Commerce: 20100300
Class 005
Cells for medical or clinical use; Pharmaceutical products for the prevention and treatment of cancer; Therapeutic pharmaceutical for the treatment of cancer
First Use Anywhere: 20100300
First Use in Commerce: 20100300

Additional Information

Pseudo Mark
CONK WEST

Classification

International Classes
001 005